149 related articles for article (PubMed ID: 15634799)
1. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform.
Von Leoprechting A; Kumpf R; Menzel S; Reulle D; Griebel R; Valler MJ; Büttner FH
J Biomol Screen; 2004 Dec; 9(8):719-25. PubMed ID: 15634799
[TBL] [Abstract][Full Text] [Related]
2. AlphaScreen-based characterization of the bifunctional kinase/RNase IRE1alpha: a novel and atypical drug target.
Bouchecareilh M; Caruso ME; Roby P; Parent S; Rouleau N; Taouji S; Pluquet O; Bossé R; Moenner M; Chevet E
J Biomol Screen; 2010 Apr; 15(4):406-17. PubMed ID: 20237204
[TBL] [Abstract][Full Text] [Related]
3. A cost-effective solution to reduce dead volume of a standard dispenser system by a factor of 5.
Bergsdorf C; Gewiese N; Stolz A; Mann R; Parczyk K; Bömer U
J Biomol Screen; 2006 Jun; 11(4):407-12. PubMed ID: 16490776
[TBL] [Abstract][Full Text] [Related]
4. Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader.
Hodder P; Mull R; Cassaday J; Berry K; Strulovici B
J Biomol Screen; 2004 Aug; 9(5):417-26. PubMed ID: 15296641
[TBL] [Abstract][Full Text] [Related]
5. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
Perrin D; Frémaux C; Scheer A
J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
[TBL] [Abstract][Full Text] [Related]
6. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
Hubert CL; Sherling SE; Johnston PA; Stancato LF
J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
[TBL] [Abstract][Full Text] [Related]
7. Miniaturized receptor binding assays: complications arising from ligand depletion.
Carter CM; Leighton-Davies JR; Charlton SJ
J Biomol Screen; 2007 Mar; 12(2):255-66. PubMed ID: 17259589
[TBL] [Abstract][Full Text] [Related]
8. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
[TBL] [Abstract][Full Text] [Related]
9. Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology.
Szekeres PG; Leong K; Day TA; Kingston AE; Karran EH
J Biomol Screen; 2008 Feb; 13(2):101-11. PubMed ID: 18216395
[TBL] [Abstract][Full Text] [Related]
10. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format.
Pommereau A; Pap E; Kannt A
J Biomol Screen; 2004 Aug; 9(5):409-16. PubMed ID: 15296640
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology.
Wilson J; Rossi CP; Carboni S; Fremaux C; Perrin D; Soto C; Kosco-Vilbois M; Scheer A
J Biomol Screen; 2003 Oct; 8(5):522-32. PubMed ID: 14567779
[TBL] [Abstract][Full Text] [Related]
12. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
13. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
Wu X; Sills MA; Zhang JH
J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
[TBL] [Abstract][Full Text] [Related]
14. Automated high throughput screening for serine kinase inhibitors using a LEADseeker scintillation proximity assay in the 1536-well format.
Sorg G; Schubert HD; Büttner FH; Heilker R
J Biomol Screen; 2002 Feb; 7(1):11-9. PubMed ID: 11897051
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
Gilchrist MA; Cacace A; Harden DG
J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
[TBL] [Abstract][Full Text] [Related]
17. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
[TBL] [Abstract][Full Text] [Related]
18. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
[TBL] [Abstract][Full Text] [Related]
19. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.
Wu X; Glickman JF; Bowen BR; Sills MA
J Biomol Screen; 2003 Aug; 8(4):381-92. PubMed ID: 14567790
[TBL] [Abstract][Full Text] [Related]
20. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases.
Iyer GH; Taslimi P; Pazhanisamy S
Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]